Matrix Laboratories Gets Tentative FDA OK For Generic Truvada
March 31 2009 - 12:58AM
Dow Jones News
Matrix Laboratories Ltd. (524794.BY) said Tuesday it has
received tentative approval from the U.S. Food and Drug
Administration for two generic HIV drugs.
Emtricitabine and tenofovir disoproxil fumarate tablets are the
generic version of Gilead Sciences Inc.'s (GILD) truvada, the
Indian drugmaker said in a statement to the Bombay Stock
Exchange.
Truvada, a second-line drug to treat HIV infection, is used when
patients develop resistance to initially prescribed treatments or
face clinical failures.
-By Satish Sarangarajan; Dow Jones Newswires; +91 22 2288 4212;
satish.sarangarajan@dowjones.com